DD209446A5 - Verfahren zur herstellung von neuen aromatischen verbindungen - Google Patents

Verfahren zur herstellung von neuen aromatischen verbindungen Download PDF

Info

Publication number
DD209446A5
DD209446A5 DD83247730A DD24773083A DD209446A5 DD 209446 A5 DD209446 A5 DD 209446A5 DD 83247730 A DD83247730 A DD 83247730A DD 24773083 A DD24773083 A DD 24773083A DD 209446 A5 DD209446 A5 DD 209446A5
Authority
DD
German Democratic Republic
Prior art keywords
compound
enyl
general formula
pyrrolidino
prop
Prior art date
Application number
DD83247730A
Other languages
German (de)
English (en)
Inventor
Geoffrey G Coker
John W A Findlay
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DD209446A5 publication Critical patent/DD209446A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Peptides Or Proteins (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Polyesters Or Polycarbonates (AREA)
DD83247730A 1982-02-04 1983-02-04 Verfahren zur herstellung von neuen aromatischen verbindungen DD209446A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8203261 1982-02-04
GB8229705 1982-10-18

Publications (1)

Publication Number Publication Date
DD209446A5 true DD209446A5 (de) 1984-05-09

Family

ID=26281898

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83247730A DD209446A5 (de) 1982-02-04 1983-02-04 Verfahren zur herstellung von neuen aromatischen verbindungen

Country Status (32)

Country Link
EP (2) EP0249950B1 (ko)
JP (2) JPS6479153A (ko)
KR (6) KR880001466B1 (ko)
AT (2) ATE64596T1 (ko)
AU (1) AU555083B2 (ko)
BG (6) BG41822A3 (ko)
CA (2) CA1249830A (ko)
CS (1) CS235306B2 (ko)
CY (1) CY1627A (ko)
DD (1) DD209446A5 (ko)
DE (2) DE3379654D1 (ko)
DK (1) DK164662C (ko)
ES (6) ES519491A0 (ko)
FI (1) FI82450C (ko)
GB (1) GB2114565B (ko)
GR (1) GR77407B (ko)
HK (1) HK25892A (ko)
HU (1) HU189223B (ko)
IE (1) IE54600B1 (ko)
IL (3) IL78419A (ko)
MC (1) MC1498A1 (ko)
NL (1) NL930057I2 (ko)
NO (2) NO162556C (ko)
NZ (1) NZ203171A (ko)
PH (1) PH21348A (ko)
PL (6) PL140812B1 (ko)
PT (1) PT76192B (ko)
SG (1) SG106091G (ko)
SI (1) SI8310221A8 (ko)
SU (1) SU1301312A3 (ko)
UY (1) UY23404A1 (ko)
YU (1) YU44821B (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4562258A (en) * 1982-02-04 1985-12-31 Findlay John W A 6-[3-Amino-1-(4-tolyl)prop-1E-enyl]pyridine-2-carboxylic acid derivatives having antihistaminic activity
US4610995A (en) * 1984-07-27 1986-09-09 Coker Geoffrey G Certain 1,1-diaryl-propenyl-3-(1-pyrrolidino-2-carboxylic acids, derivatives thereof and their anti-histaminic properties
LU86387A1 (fr) * 1986-04-04 1987-12-07 Oreal Composes aromatiques,leur procede de preparation et leur utilisation en medicine humaine et veterinaire et en cosmetique
GB8707416D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
DE3711866A1 (de) * 1987-04-08 1988-10-27 Hoechst Ag Synthese von peptidamiden mittels festphasenmethode unter verwendung von saeurelabilen ankergruppen
IL94768A (en) * 1989-06-19 1995-08-31 Wellcome Found Use of Reliable History Transformed by Aril for the Preparation of Pharmaceuticals
GB8914060D0 (en) * 1989-06-19 1989-08-09 Wellcome Found Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
GB8914040D0 (en) * 1989-06-19 1989-08-09 Wellcome Found Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
FR2711651B1 (fr) * 1993-10-28 1995-12-22 Adir Nouveaux analogues cyclisés de métabolites d'acides gras, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
US5420866A (en) * 1994-03-29 1995-05-30 Scientific-Atlanta, Inc. Methods for providing conditional access information to decoders in a packet-based multiplexed communications system
GB9508748D0 (en) * 1995-04-28 1995-06-14 British Biotech Pharm Benzimidazole derivatives
JPH11510180A (ja) * 1995-08-05 1999-09-07 ブリティッシュ バイオテック ファーマシューティカルズ リミテッド イミダゾピリジン誘導体
IT1277597B1 (it) * 1995-09-15 1997-11-11 Smithkline Beecham Spa Derivati di diarilalchenilammina
CN101838235B (zh) * 2009-06-12 2013-08-07 重庆华邦制药有限公司 3-苯基-3＇-吡啶基丙烯胺类化合物及其合成方法
CN103124723A (zh) * 2010-09-23 2013-05-29 先正达参股股份有限公司 新颖的杀微生物剂
CN104254589B (zh) 2012-04-23 2016-06-15 沙特基础工业公司 基于太阳能的连续方法和用于通过相应的烷烃脱氢生产烯烃的反应器系统

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2567245A (en) * 1948-05-10 1951-09-11 Schering Corp Aryl-(2-pyridyl)-amino alkanes and their production
DE1227464B (de) * 1951-09-10 1966-10-27 Wellcome Found Verfahren zur Herstellung der trans-Form des neuen 1-(4'-Methylphenyl)-1-(2''-pyridyl)-3-pyrrolidinopropens-(1)
FR1228801A (fr) * 1954-05-03 1960-09-02 Farbwerke Hoechst Ag Vomals Me Procédé de préparation de composés tertio-amino carboxyliques et des composés tertio-amino cétoniques correspondants
FR2197583B1 (ko) * 1972-09-07 1975-10-17 Rhone Poulenc Ind

Also Published As

Publication number Publication date
AU1098283A (en) 1983-08-11
PL140708B1 (en) 1987-05-30
SG106091G (en) 1992-03-20
PT76192A (en) 1983-03-01
PT76192B (en) 1986-01-24
EP0085959A2 (en) 1983-08-17
YU44821B (en) 1991-02-28
SI8310221A8 (en) 1995-10-31
DK43683D0 (da) 1983-02-03
BG41822A3 (en) 1987-08-14
ES523415A0 (es) 1984-10-01
FI830380L (fi) 1983-08-05
ES8500235A1 (es) 1984-10-01
NL930057I1 (nl) 1993-09-01
ES8500233A1 (es) 1984-10-01
ES523418A0 (es) 1984-10-01
GR77407B (ko) 1984-09-13
KR840003628A (ko) 1984-09-15
EP0085959B1 (en) 1989-04-19
PL240412A1 (en) 1985-01-30
EP0249950A1 (en) 1987-12-23
PL140811B1 (en) 1987-05-30
KR880001466B1 (ko) 1988-08-11
KR870001915B1 (ko) 1987-10-22
ES523417A0 (es) 1984-10-01
NL930057I2 (nl) 1994-02-16
UY23404A1 (es) 1992-10-19
CA1275102A (en) 1990-10-09
AU555083B2 (en) 1986-09-11
DK43683A (da) 1983-08-05
PL140809B1 (en) 1987-05-30
CA1249830A (en) 1989-02-07
ES523414A0 (es) 1984-10-01
EP0249950B1 (en) 1991-06-19
NO874330L (no) 1983-08-05
ATE64596T1 (de) 1991-07-15
JPH0251897B2 (ko) 1990-11-08
IE54600B1 (en) 1989-12-06
CS235306B2 (en) 1985-05-15
PL245842A1 (en) 1985-01-30
PL245845A1 (en) 1985-01-30
PL140812B1 (en) 1987-05-30
ES8500231A1 (es) 1984-10-01
DK164662B (da) 1992-07-27
YU22183A (en) 1986-02-28
ES8403872A1 (es) 1984-04-01
PL141639B1 (en) 1987-08-31
JPS6479153A (en) 1989-03-24
JPH01301661A (ja) 1989-12-05
PL245843A1 (en) 1985-01-30
JPH0468B2 (ko) 1992-01-06
PL140810B1 (en) 1987-05-30
DE3382321D1 (de) 1991-07-25
NO172341B (no) 1993-03-29
NO830368L (no) 1983-08-05
FI82450C (fi) 1991-03-11
BG42003A3 (en) 1987-09-15
NZ203171A (en) 1986-12-05
IL67829A (en) 1988-06-30
BG42185A3 (en) 1987-10-15
IE830213L (en) 1983-08-04
DE3379654D1 (en) 1989-05-24
ES8500232A1 (es) 1984-10-01
MC1498A1 (fr) 1983-11-17
IL78419A0 (en) 1986-08-31
GB2114565A (en) 1983-08-24
HU189223B (en) 1986-06-30
PL245844A1 (en) 1985-01-30
EP0085959A3 (en) 1984-07-18
KR870001916B1 (ko) 1987-10-22
IL78419A (en) 1989-01-31
GB8302971D0 (en) 1983-03-09
ATE42282T1 (de) 1989-05-15
SU1301312A3 (ru) 1987-03-30
ES8500234A1 (es) 1984-10-01
DK164662C (da) 1992-12-14
HK25892A (en) 1992-04-16
BG41821A3 (en) 1987-08-14
KR870001927B1 (ko) 1987-10-22
CY1627A (en) 1992-07-10
FI82450B (fi) 1990-11-30
GB2114565B (en) 1985-06-26
ES523416A0 (es) 1984-10-01
BG42004A3 (en) 1987-09-15
NO172341C (no) 1993-07-07
FI830380A0 (fi) 1983-02-03
NO162556B (no) 1989-10-09
PL245841A1 (en) 1985-01-30
BG42005A3 (en) 1987-09-15
NO874330D0 (no) 1987-10-16
NO162556C (no) 1990-01-17
IL67829A0 (en) 1983-06-15
PH21348A (en) 1987-10-13
ES519491A0 (es) 1984-04-01
KR870001918B1 (ko) 1987-10-22
KR870001917B1 (ko) 1987-10-22
CA1275102C (ko) 1990-10-09

Similar Documents

Publication Publication Date Title
DE3047142C2 (de) Basische 1,7,7-Trimethylbicyclo[2,2,1]heptyläther, Verfahren zur Herstellung derselben und diese enthaltende Arzneimittel
US4501893A (en) 3-{6-[3-Pyrrolidino-1-(4-tolyl)prop-1-enyl]-2-pyridyl}acrylic acid and pharmaceutically acceptable salts thereof
DD209446A5 (de) Verfahren zur herstellung von neuen aromatischen verbindungen
DE2835701C2 (de) Cycloalkylidenmethylphenylessigsäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE3032669A1 (de) Substituierte oxirancarbonsaeuren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel
CH633249A5 (de) Verfahren zur herstellung von neuen polyprenylderivaten.
CH646426A5 (en) Process for the preparation of hydantoin derivatives
EP0185909B1 (de) 5-Alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3035086A1 (de) Cyclohexancarbonsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende mittel
EP0090369A1 (de) Salicylsäurederivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen und ihre Verwendung
EP0072960B1 (de) 1,5-Diphenylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2929760C2 (ko)
DE60207273T2 (de) Aminopyrrolverbindungen als entzündungshemmende Wirkstoffe
EP0027268A2 (de) Chinazolin-Derivate, Verfahren und Zwischenprodukte zu deren Herstellung, Arzneimittel enthaltend solche Chinazolin-Derivate und deren pharmazeutische Verwendung
DD211559A5 (de) Verfahren zur herstellung bicyclischer, benzokondensierter verbindungen
DE2412520A1 (de) Tricyclische verbindungen
DD300542A5 (de) Chemische verbindungen
DE2253914A1 (de) Neue chromonderivate und verfahren zu ihrer herstellung
US4621094A (en) Anti-histaminic pyridyl compounds
DE2814168A1 (de) Neue 1- eckige klammer auf 3-(3,4,5- trimethoxyphenoxy)-2-hydroxypropyl eckige klammer zu -4-aryl-piperazin-derivate und verfahren zu ihrer herstellung
DE1668968A1 (de) Neue organische Verbindungen
DD217799A5 (de) Verfahren zur herstellung von therphenylderivaten
DE2234706A1 (de) Derivate von 9-oxo-13-trans-prostensaeureestern
DE3873720T2 (de) Nicotinoylpiperazin-derivate, verfahren zu ihrer herstellung und ihre verwendung in der therapie.
AT387964B (de) Verfahren zur herstellung von neuen piperazinderivaten und von enantiomeren oder diastereomeren davon

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee